SCHEMBL23217953

SCHEMBL23217953

Cc1cccc(C(=O)Cc2ccc3ncc(OCCNC(=O)OC(C)(C)C)nc3c2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.36
SCN9A Q15858 1/20 0.36
BCHE P06276 1/20 0.36
NQO2 P16083 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
CKS1B P61024 1/20 0.35
SKP1 P63208 1/20 0.35
SKP2 Q13309 1/20 0.35
SUCNR1 Q9BXA5 3/20 0.35
IDO1 P14902 1/20 0.35
EGFR P00533 1/20 0.35
ITK Q08881 1/20 0.35
KDM4E B2RXH2 3/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NAMPT P43490 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23217905 0.86 CA12 (0.40) PDK2SCN9ABCHECA12CA1
SCHEMBL23217900 0.85 GABRA5 (0.38) PDK2SCN9ANQO2CA12CA1
SCHEMBL23217952 0.82 TGFBR1 (0.33) BCHECKS1BSKP1SKP2KDM4E
SCHEMBL23217974 0.77 CA12 (0.43) PDK2SCN9ABCHENQO2CA12
SCHEMBL23217968 0.75 KDM4E (0.48) PDK2SCN9ABCHENQO2CA12
SCHEMBL30131266 0.75 CA12 (0.49) PDK2SCN9ABCHENQO2CA12
SCHEMBL23217944 0.74 TGFBR1 (0.48) BCHECKS1BSKP1SKP2SUCNR1
SCHEMBL23217959 0.73 TGFBR1 (0.41) BCHECKS1BSKP1SKP2SUCNR1
SCHEMBL23217910 0.73 CA12 (0.40) PDK2SCN9ABCHECA12CA1
SCHEMBL14576794 0.72 NPC1 (0.48) TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2022006340-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-01-06 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed